CLINICAL TRIALS PROFILE FOR ROGAINE (FOR WOMEN)

All Clinical Trials for ROGAINE (FOR WOMEN)

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01309191 ↗	Microarray Analysis of Scalp Biopsies After Minoxidil Treatment	Completed	Kaiser Permanente	N/A	2011-04-01	The purpose of this study is to determine whether Minoxidil treatment affects hair growth in patients with male pattern baldness or androgenetic alopecia.
NCT01309191 ↗	Microarray Analysis of Scalp Biopsies After Minoxidil Treatment	Completed	University of California, San Francisco	N/A	2011-04-01	The purpose of this study is to determine whether Minoxidil treatment affects hair growth in patients with male pattern baldness or androgenetic alopecia.
NCT01309191 ↗	Microarray Analysis of Scalp Biopsies After Minoxidil Treatment	Completed	University Hospitals Cleveland Medical Center	N/A	2011-04-01	The purpose of this study is to determine whether Minoxidil treatment affects hair growth in patients with male pattern baldness or androgenetic alopecia.
NCT03488108 ↗	Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women	Completed	Mayo Clinic	Phase 1/Phase 2	2017-01-23	The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.
NCT03852992 ↗	Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia	Not yet recruiting	University of Minnesota	Phase 2	2021-09-01	The objective of this study is to evaluate the safety and efficacy of fractionated ablative 10,600nm CO2 laser assisted delivery of 2% minoxidil solution in the treatment of MPHL. In this cohort study, patients will randomly be assigned stand-alone laser treatment, laser assisted drug delivery of minoxidil 2% solution, and laser assisted drug delivery of minoxidil 2% solution plus at home 5% minoxidil treatment. The primary endpoints will be to assess the change from baseline in investigator and subject Hair Growth Assessments (HGA), Hair Growth Index (HGI) and the Hair Growth Satisfaction Scale (HGSS) over 8-12 weeks in each of the three groups. The secondary endpoints will be expert assessment of hair density from baseline and evaluation of safety and adverse events, and pharmacokinetic (PK) data.
NCT03852992 ↗	Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia	Not yet recruiting	University of Minnesota - Clinical and Translational Science Institute	Phase 2	2021-09-01	The objective of this study is to evaluate the safety and efficacy of fractionated ablative 10,600nm CO2 laser assisted delivery of 2% minoxidil solution in the treatment of MPHL. In this cohort study, patients will randomly be assigned stand-alone laser treatment, laser assisted drug delivery of minoxidil 2% solution, and laser assisted drug delivery of minoxidil 2% solution plus at home 5% minoxidil treatment. The primary endpoints will be to assess the change from baseline in investigator and subject Hair Growth Assessments (HGA), Hair Growth Index (HGI) and the Hair Growth Satisfaction Scale (HGSS) over 8-12 weeks in each of the three groups. The secondary endpoints will be expert assessment of hair density from baseline and evaluation of safety and adverse events, and pharmacokinetic (PK) data.
NCT04207931 ↗	Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study	Recruiting	The Skin of Color Society	Phase 4	2018-04-30	The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Clinical Trial Conditions for ROGAINE (FOR WOMEN)

Condition Name

Condition Name for ROGAINE (FOR WOMEN)
Intervention	Trials
Androgenetic Alopecia	2
Prognostic Stage II Breast Cancer AJCC v8	1
Alopecia	1
Anatomic Stage IV Breast Cancer AJCC v8	1

Condition MeSH

Condition MeSH for ROGAINE (FOR WOMEN)
Intervention	Trials
Alopecia	5
Alopecia Areata	5
Breast Neoplasms	1
Ovarian Neoplasms	1

Clinical Trial Locations for ROGAINE (FOR WOMEN)

Trials by Country

Trials by Country for ROGAINE (FOR WOMEN)
Location	Trials
United States	6

Trials by US State

Trials by US State for ROGAINE (FOR WOMEN)
Location	Trials
Ohio	2
Illinois	1
North Carolina	1
Minnesota	1
Florida	1

Clinical Trial Progress for ROGAINE (FOR WOMEN)

Clinical Trial Phase

Clinical Trial Phase for ROGAINE (FOR WOMEN)
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for ROGAINE (FOR WOMEN)
Clinical Trial Phase	Trials
Completed	2
Not yet recruiting	2
Recruiting	2

Clinical Trial Sponsors for ROGAINE (FOR WOMEN)

Sponsor Name

Sponsor Name for ROGAINE (FOR WOMEN)
Sponsor	Trials
Ohio State University Comprehensive Cancer Center	1
Kaiser Permanente	1
University of California, San Francisco	1

Sponsor Type

Sponsor Type for ROGAINE (FOR WOMEN)
Sponsor	Trials
Other	11